4//SEC Filing
Elston George 4
Accession 0001562180-25-001135
CIK 0001314102other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 6:19 PM ET
Size
7.4 KB
Accession
0001562180-25-001135
Insider Transaction Report
Form 4
Elston George
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-02-09+5,834→ 75,550 total - Exercise/Conversion
Restricted Stock Units
2025-02-09−5,834→ 0 totalExercise: $0.00→ Common Stock (5,834 underlying)
Footnotes (2)
- [F1]Includes 1,150 shares acquired on January 31, 2025 pursuant to EyePoint's 2019 Employee Stock Purchase Plan.
- [F2]The restricted stock units will vest in three ratable annual installments beginning February 9, 2023.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001429932
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 6:19 PM ET
- Size
- 7.4 KB